Status:
TERMINATED
Compare Visual Outcomes Using a New Diagnostic Device
Lead Sponsor:
Carl Zeiss Meditec AG
Conditions:
Presbyopia
Eligibility:
All Genders
18+ years
Brief Summary
Evaluation of preoperative corrected distance visual acuity (CDVA) obtained with VirtIOL device compared to postoperative CDVA.
Eligibility Criteria
Inclusion
- Patient informed of the consequences and constraints of the protocol and who has given his/her written informed consent
- Patients of any gender, aged 18 years to open age
- Assured follow-up examinations
- Healthy eyes without clinically significant age-related cataract
Exclusion
- Patients unable to meet the limitations of the protocol or likely of non-cooperation during the trial
- Patients whose freedom is impaired by administrative or legal order
- Concurrent participation in another drug or device investigation
Key Trial Info
Start Date :
July 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04037631
Start Date
July 20 2017
End Date
May 1 2020
Last Update
January 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Internationale Innovative Ophthalmologie
Düsseldorf, Germany, 40549